LRG1 | Leucine-rich alpha-2-glycoprotein 1 | Plasma proteins Predicted secreted proteins
| | ![](/images_static/na_center.gif) | ![](/images/1888/ihc_cell_selected_60x60.jpg) | ![](/images/1888/7047_B_8_6_rna_selected_60x60.jpg) | Tissue enriched |
SLC6A1 | Solute carrier family 6 (neurotransmitter transporter), member 1 | FDA approved drug targets Predicted intracellular proteins Predicted membrane proteins Transporters
| | ![](/images/13341/if_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/22293/56979_B_8_5_rna_selected_60x60.jpg) | Group enriched |
TTC36 | Tetratricopeptide repeat domain 36 | Predicted intracellular proteins
| | ![](/images/38731/if_selected_60x60.jpg) | ![](/images/38731/ihc_cell_selected_60x60.jpg) | ![](/images/38731/81619_B_8_6_rna_selected_60x60.jpg) | Tissue enriched |
ABCB11 | ATP-binding cassette, sub-family B (MDR/TAP), member 11 | Disease related genes Potential drug targets Predicted membrane proteins Transporters
| | ![](/images/19035/if_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/19035/49514_B_7_7_rna_selected_60x60.jpg) | Tissue enriched |
CFB | Complement factor B | Disease related genes Enzymes Plasma proteins Potential drug targets Predicted intracellular proteins Predicted secreted proteins
| | ![](/images/1817/if_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/1832/6332_B_8_1_rna_selected_60x60.jpg) | Tissue enriched |
CLEC4M | C-type lectin domain family 4, member M | CD markers Predicted intracellular proteins Predicted membrane proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/33689/80801_B_9_1_rna_selected_60x60.jpg) | Group enriched |
HNF4A | Hepatocyte nuclear factor 4, alpha | Disease related genes Nuclear receptors Predicted intracellular proteins Transcription factors
| | | ![](/images_static/rna_center.gif) | ![](/images/19417/51796_B_8_6_rna_selected_60x60.jpg) | Group enriched |
SULT1E1 | Sulfotransferase family 1E, estrogen-preferring, member 1 | Cancer-related genes Enzymes Predicted intracellular proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/47344/105419_B_8_4_rna_selected_60x60.jpg) | Group enriched |
C6 | Complement component 6 | Cancer-related genes Disease related genes Plasma proteins Potential drug targets Predicted secreted proteins Transporters
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/69427/149128_A_9_6_rna_selected_60x60.jpg) | Group enriched |
EHHADH | Enoyl-CoA, hydratase/3-hydroxyacyl CoA dehydrogenase | Disease related genes Enzymes Plasma proteins Potential drug targets Predicted intracellular proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/42021/147568_B_7_2_rna_selected_60x60.jpg) | Group enriched |
GATM | Glycine amidinotransferase (L-arginine:glycine amidinotransferase) | Disease related genes Enzymes Mitochondrial proteins Plasma proteins Potential drug targets Predicted intracellular proteins
| | | ![](/images_static/rna_center.gif) | ![](/images/26077/55476_B_9_1_rna_selected_60x60.jpg) | Group enriched |
SARDH | Sarcosine dehydrogenase | Disease related genes Enzymes Mitochondrial proteins Plasma proteins Potential drug targets Predicted intracellular proteins
| | ![](/images/58086/if_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/57267/132108_B_8_4_rna_selected_60x60.jpg) | Group enriched |
SORD | Sorbitol dehydrogenase | Enzymes Plasma proteins Predicted intracellular proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/40260/89202_B_8_8_rna_selected_60x60.jpg) | Group enriched |
ACY1 | Aminoacylase 1 | Disease related genes Enzymes Plasma proteins Potential drug targets Predicted intracellular proteins
| | ![](/images/36175/if_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/36174/98822_B_8_3_rna_selected_60x60.jpg) | Group enriched |
ADH1B | Alcohol dehydrogenase 1B (class I), beta polypeptide | Enzymes FDA approved drug targets Plasma proteins Predicted intracellular proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/60902/141575_B_8_3_rna_selected_60x60.jpg) | Group enriched |
ADH1C | Alcohol dehydrogenase 1C (class I), gamma polypeptide | Enzymes FDA approved drug targets Plasma proteins Predicted intracellular proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/47814/113135_B_3_2_rna_selected_60x60.jpg) | Group enriched |
AZGP1 | Alpha-2-glycoprotein 1, zinc-binding | Cancer-related genes Plasma proteins Predicted intracellular proteins Predicted secreted proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/16087/35797_B_1_4_rna_selected_60x60.jpg) | Group enriched |
C3 | Complement component 3 | Candidate cardiovascular disease genes Disease related genes FDA approved drug targets Plasma proteins Predicted intracellular proteins Predicted secreted proteins
| | ![](/images_static/na_center.gif) | | ![](/images/4209/12200_B_8_1_rna_selected_60x60.jpg) | Tissue enriched |
GCKR | Glucokinase (hexokinase 4) regulator | Predicted intracellular proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/34098/76385_B_9_1_rna_selected_60x60.jpg) | Tissue enriched |
HAL | Histidine ammonia-lyase | Disease related genes Enzymes Plasma proteins Potential drug targets Predicted intracellular proteins
| | ![](/images/38548/if_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/38547/80967_A_1_8_rna_selected_60x60.jpg) | Group enriched |
HSD11B1 | Hydroxysteroid (11-beta) dehydrogenase 1 | Disease related genes Enzymes Potential drug targets Predicted intracellular proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/47729/125055_B_9_8_rna_selected_60x60.jpg) | Tissue enriched |
PCK2 | Phosphoenolpyruvate carboxykinase 2 (mitochondrial) | Citric acid cycle related proteins Disease related genes Enzymes Mitochondrial proteins Plasma proteins Potential drug targets Predicted intracellular proteins
| | | ![](/images/51162/ihc_cell_selected_60x60.jpg) | ![](/images/51162/124857_B_8_2_rna_selected_60x60.jpg) | Group enriched |
PLG | Plasminogen | Cancer-related genes Candidate cardiovascular disease genes Disease related genes Enzymes FDA approved drug targets Plasma proteins Predicted secreted proteins
| | ![](/images_static/na_center.gif) | ![](/images/668/ihc_cell_selected_60x60.jpg) | ![](/images/668/1156_B_8_5_rna_selected_60x60.jpg) | Tissue enriched |
PZP | Pregnancy-zone protein | Cancer-related genes Plasma proteins Predicted secreted proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/41471/95384_B_8_6_rna_selected_60x60.jpg) | Tissue enriched |
RGN | Regucalcin | Enzymes Plasma proteins Predicted intracellular proteins
| | | ![](/images_static/rna_center.gif) | ![](/images/29103/67326_B_9_4_rna_selected_60x60.jpg) | Group enriched |
UGT2B17 | UDP glucuronosyltransferase 2 family, polypeptide B17 | Enzymes Predicted membrane proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/45108/105018_B_9_1_rna_selected_60x60.jpg) | Group enriched |
AGTR1 | Angiotensin II receptor, type 1 | Disease related genes FDA approved drug targets G-protein coupled receptors Predicted membrane proteins Transporters
| | ![](/images_static/na_center.gif) | ![](/images/3596/ihc_cell_selected_60x60.jpg) | ![](/images/3596/11016_B_9_3_rna_selected_60x60.jpg) | Group enriched |
ALDH6A1 | Aldehyde dehydrogenase 6 family, member A1 | Disease related genes Enzymes Mitochondrial proteins Potential drug targets Predicted intracellular proteins Predicted membrane proteins
| | | | ![](/images/29074/65842_A_2_6_rna_selected_60x60.jpg) | Group enriched |
ASS1 | Argininosuccinate synthase 1 | Disease related genes Enzymes Plasma proteins Potential drug targets Predicted intracellular proteins
| | | | ![](/images/20896/48102_B_2_1_rna_selected_60x60.jpg) | Group enriched |
CLEC4G | C-type lectin domain family 4, member G | Predicted intracellular proteins Predicted membrane proteins
| | ![](/images/14044/if_selected_60x60.jpg) | ![](/images/14044/ihc_cell_selected_60x60.jpg) | ![](/images/3789/10114_B_2_1_rna_selected_60x60.jpg) | Group enriched |
CRP | C-reactive protein, pentraxin-related | Cancer-related genes Candidate cardiovascular disease genes Plasma proteins Predicted intracellular proteins Predicted secreted proteins
| | ![](/images_static/na_center.gif) | ![](/images/5036/ihc_cell_selected_60x60.jpg) | ![](/images/5036/15290_B_9_3_rna_selected_60x60.jpg) | Tissue enriched |
CYP2C9 | Cytochrome P450, family 2, subfamily C, polypeptide 9 | Enzymes Predicted secreted proteins
| | ![](/images_static/na_center.gif) | ![](/images/16123/ihc_cell_selected_60x60.jpg) | ![](/images/16123/35060_B_9_1_rna_selected_60x60.jpg) | Tissue enriched |
GAS2 | Growth arrest-specific 2 | Predicted intracellular proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/58904/138135_B_8_4_rna_selected_60x60.jpg) | Tissue enriched |
GC | Group-specific component (vitamin D binding protein) | Plasma proteins Predicted secreted proteins
| | ![](/images_static/na_center.gif) | ![](/images/1526/ihc_cell_selected_60x60.jpg) | ![](/images/1526/4387_B_7_3_rna_selected_60x60.jpg) | Tissue enriched |
HNF1A | HNF1 homeobox A | Cancer-related genes Predicted intracellular proteins
| | | ![](/images_static/rna_center.gif) | ![](/images/35231/124724_A_9_6_rna_selected_60x60.jpg) | Group enriched |
IGFBP1 | Insulin-like growth factor binding protein 1 | Candidate cardiovascular disease genes Plasma proteins Predicted secreted proteins
| | ![](/images_static/na_center.gif) | ![](/images/46972/158028_A_2_6_selected_60x60.jpg) | ![](/images/46972/146495_B_7_7_rna_selected_60x60.jpg) | Group enriched |
NPC1L1 | NPC1-like 1 | FDA approved drug targets Predicted membrane proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/70127/151478_B_8_6_rna_selected_60x60.jpg) | Group enriched |
SLC27A2 | Solute carrier family 27 (fatty acid transporter), member 2 | Enzymes Predicted membrane proteins Transporters
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/26089/55453_B_8_1_rna_selected_60x60.jpg) | Group enriched |
SLC2A2 | Solute carrier family 2 (facilitated glucose transporter), member 2 | Disease related genes Potential drug targets Predicted membrane proteins Transporters
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/10444/33031_B_9_1_rna_selected_60x60.jpg) | Tissue enriched |
STAB2 | Stabilin 2 | Plasma proteins Predicted intracellular proteins Predicted membrane proteins
| | ![](/images/26871/if_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/26871/57572_B_9_2_rna_selected_60x60.jpg) | Group enriched |
A1CF | APOBEC1 complementation factor | Predicted intracellular proteins
| | | ![](/images_static/rna_center.gif) | ![](/images/44079/132428_B_8_7_rna_selected_60x60.jpg) | Tissue enhanced |
ABAT | 4-aminobutyrate aminotransferase | Disease related genes Enzymes FDA approved drug targets Mitochondrial proteins Plasma proteins Predicted intracellular proteins
| | ![](/images_static/na_center.gif) | | ![](/images/41528/91017_B_9_1_rna_selected_60x60.jpg) | Tissue enhanced |
ADAMTS13 | ADAM metallopeptidase with thrombospondin type 1 motif, 13 | Disease related genes Enzymes Plasma proteins Potential drug targets Predicted intracellular proteins Predicted secreted proteins
| | ![](/images/42014/if_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/42014/98164_B_8_6_rna_selected_60x60.jpg) | Tissue enhanced |
APOA1 | Apolipoprotein A-I | Cancer-related genes Candidate cardiovascular disease genes Disease related genes Plasma proteins Predicted intracellular proteins Predicted secreted proteins
| | ![](/images/46715/if_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/16778/39552_B_8_5_rna_selected_60x60.jpg) | Tissue enhanced |
ARG1 | Arginase 1 | Disease related genes Enzymes Plasma proteins Potential drug targets Predicted intracellular proteins
| | ![](/images/3595/if_selected_60x60.jpg) | ![](/images/3595/ihc_cell_selected_60x60.jpg) | ![](/images/3595/11122_B_9_1_rna_selected_60x60.jpg) | Tissue enhanced |
C2 | Complement component 2 | Disease related genes Enzymes Plasma proteins Potential drug targets Predicted intracellular proteins Predicted secreted proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/16775/38385_B_8_1_rna_selected_60x60.jpg) | Tissue enhanced |
CBS | Cystathionine-beta-synthase | Disease related genes Enzymes Plasma proteins Potential drug targets Predicted intracellular proteins
| | ![](/images/1223/if_selected_60x60.jpg) | | ![](/images/1223/5627_B_8_1_rna_selected_60x60.jpg) | Tissue enhanced |
CBS | Cystathionine-beta-synthase | Predicted intracellular proteins
| | ![](/images/1223/if_selected_60x60.jpg) | | ![](/images/1223/5625_A_3_1_rna_selected_60x60.jpg) | Tissue enhanced |
CDO1 | Cysteine dioxygenase type 1 | Enzymes Predicted intracellular proteins
| | ![](/images/36573/if_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/57503/137455_B_8_5_rna_selected_60x60.jpg) | Tissue enhanced |
CLDN1 | Claudin 1 | Disease related genes Predicted membrane proteins
| | ![](/images_static/na_center.gif) | ![](/images/48319/122922_A_1_10_selected_60x60.jpg) | ![](/images/48319/122919_B_9_4_rna_selected_60x60.jpg) | Tissue enhanced |